Participants in a double-blind trial on depression found temporary relief with a synthetic formulation of psilocybin, COMP360.
COMPASS Pathways psilocybin study shows a significant improvement in treatment-resistant depression symptoms.
Participants in a double-blind trial on depression found temporary relief with a synthetic formulation of psilocybin, COMP360.
COMPASS Pathways psilocybin study shows a significant improvement in treatment-resistant depression symptoms.
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!